Emil M deGoma

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. pmc The evolution and refinement of traditional risk factors for cardiovascular disease
    Emil M deGoma
    Division of Cardiovascular Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA
    Cardiol Rev 20:118-29. 2012
  2. doi request reprint Discordance between non-HDL-cholesterol and LDL-particle measurements: results from the Multi-Ethnic Study of Atherosclerosis
    Emil M deGoma
    Division of Cardiovascular Medicine, Perelman School of Medicine at the University of Pennsylvania, PA, USA
    Atherosclerosis 229:517-23. 2013
  3. doi request reprint Differences in absolute risk of cardiovascular events using risk-refinement tests: a systematic analysis of four cardiovascular risk equations
    Emil M deGoma
    Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, PA, USA
    Atherosclerosis 227:172-7. 2013
  4. doi request reprint Intraindividual variability of C-reactive protein: the Multi-Ethnic Study of Atherosclerosis
    Emil M deGoma
    Division of Cardiovascular Medicine, University of Pennsylvania, Perelman Center for Advanced Medicine, Heart and Vascular Center, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA
    Atherosclerosis 224:274-9. 2012
  5. pmc Personalized vascular medicine: individualizing drug therapy
    Emil M deGoma
    Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, USA
    Vasc Med 16:391-404. 2011
  6. pmc Novel HDL-directed pharmacotherapeutic strategies
    Emil M deGoma
    Division of Cardiovascular Medicine, University of Pennsylvania, Penn Tower, 6th Floor, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Nat Rev Cardiol 8:266-77. 2011
  7. doi request reprint Guidewire embolization and right ventricular perforation visualized by cardiac CT
    Emil M deGoma
    Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    J Cardiovasc Comput Tomogr 5:61-2. 2011
  8. doi request reprint The underappreciated impact of heart disease
    Emil M deGoma
    Cardiovascular Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Womens Health Issues 20:299-303. 2010
  9. pmc Targeting high density lipoproteins in the prevention of cardiovascular disease?
    Daniel B Larach
    Perelman School of Medicine at the University of Pennsylvania, Philadelphia, 19104, USA
    Curr Cardiol Rep 14:684-91. 2012
  10. doi request reprint Pharmacologic interactions of multidrug therapy for dyslipidemia
    Nidhi Mehta
    Division of Cardiovascular Medicine, Perelman School of Medicine at the University of Pennsylvania, 9 Gates Building 3400 Spruce Street, Philadelphia, PA 19103, USA
    Curr Atheroscler Rep 15:303. 2013

Detail Information

Publications11

  1. pmc The evolution and refinement of traditional risk factors for cardiovascular disease
    Emil M deGoma
    Division of Cardiovascular Medicine, University of Pennsylvania, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA
    Cardiol Rev 20:118-29. 2012
    ....
  2. doi request reprint Discordance between non-HDL-cholesterol and LDL-particle measurements: results from the Multi-Ethnic Study of Atherosclerosis
    Emil M deGoma
    Division of Cardiovascular Medicine, Perelman School of Medicine at the University of Pennsylvania, PA, USA
    Atherosclerosis 229:517-23. 2013
    ..It remains uncertain under which circumstances atherogenic lipoprotein enumeration such as LDL particle number (LDL-P) differs from simultaneously acquired non-HDL-C...
  3. doi request reprint Differences in absolute risk of cardiovascular events using risk-refinement tests: a systematic analysis of four cardiovascular risk equations
    Emil M deGoma
    Division of Cardiovascular Medicine, Perelman School of Medicine, University of Pennsylvania, PA, USA
    Atherosclerosis 227:172-7. 2013
    ..However, the effect of these suggested thresholds of relative risk on absolute global risk remains uncertain...
  4. doi request reprint Intraindividual variability of C-reactive protein: the Multi-Ethnic Study of Atherosclerosis
    Emil M deGoma
    Division of Cardiovascular Medicine, University of Pennsylvania, Perelman Center for Advanced Medicine, Heart and Vascular Center, 3400 Civic Center Boulevard, Philadelphia, PA 19104, USA
    Atherosclerosis 224:274-9. 2012
    ..We sought to compare the intraindividual variability of CRP with that of cholesterol measures using the multi-ethnic study of atherosclerosis (MESA)...
  5. pmc Personalized vascular medicine: individualizing drug therapy
    Emil M deGoma
    Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, USA
    Vasc Med 16:391-404. 2011
    ..Translation to routine clinical practice awaits the results of ongoing randomized clinical trials comparing personalized approaches with standard of care management...
  6. pmc Novel HDL-directed pharmacotherapeutic strategies
    Emil M deGoma
    Division of Cardiovascular Medicine, University of Pennsylvania, Penn Tower, 6th Floor, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Nat Rev Cardiol 8:266-77. 2011
    ....
  7. doi request reprint Guidewire embolization and right ventricular perforation visualized by cardiac CT
    Emil M deGoma
    Division of Cardiovascular Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    J Cardiovasc Comput Tomogr 5:61-2. 2011
    ....
  8. doi request reprint The underappreciated impact of heart disease
    Emil M deGoma
    Cardiovascular Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Womens Health Issues 20:299-303. 2010
    ....
  9. pmc Targeting high density lipoproteins in the prevention of cardiovascular disease?
    Daniel B Larach
    Perelman School of Medicine at the University of Pennsylvania, Philadelphia, 19104, USA
    Curr Cardiol Rep 14:684-91. 2012
    ....
  10. doi request reprint Pharmacologic interactions of multidrug therapy for dyslipidemia
    Nidhi Mehta
    Division of Cardiovascular Medicine, Perelman School of Medicine at the University of Pennsylvania, 9 Gates Building 3400 Spruce Street, Philadelphia, PA 19103, USA
    Curr Atheroscler Rep 15:303. 2013
    ..In the past few years, several landmark trials have provided important information regarding the efficacy and safety of non-statin therapy for dyslipidemia and cardiovascular risk reduction...
  11. pmc Approach to the patient with extremely low HDL-cholesterol
    Daniel J Rader
    Cardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, 11 125 Translational Research Center, 3400 Civic Center Boulevard, Philadelphia, Pennsylvania 19104, USA
    J Clin Endocrinol Metab 97:3399-407. 2012
    ..Uncommon encounters with patients exhibiting extremely low HDL-C provide an opportunity to directly observe the role of HDL metabolism in atherosclerosis and beyond the vascular system...